SELLAS Life Sciences Group, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
SLS chart
What traders are saying about $SLS
Latest postsSELLAS Life Sciences Group, Inc. news
- Pomerantz probes SELLAS Life Sciences over delayed trial data
scanx.trade ·
- Barclays, Deutsche Bank Reveal Stakes In Retail-Favorite Cancer Stocks SLS, IBRX And IOVA — Geode Adds More
stocktwits.com ·
- SELLAS Life Sciences Group, Inc. (SLS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- SELLAS Life Sciences Group, Inc. (SLS) stock price, news, quote and history
Yahoo Finance UK ·
- Sellas Life Sciences Group Stock Price Forecast. Should You Buy SLS?
StockInvest.us ·
- SELLAS Life Sciences Group (SLS) Stock Could Be Fully Priced On Phase 3 Analysis Trigger
Yahoo Finance ·
- SELLAS Life Sciences Group, Inc. (RXK3.F) Seasonal returns chart
Yahoo Finance UK ·
- Does Final Trial Analysis Change The Bull Case For SELLAS Life Sciences Group (SLS)?
Simply Wall St ·
- SELLAS Life Sciences Group (Nasdaq:SLS) - Stock Analysis
Simply Wall St ·
- SLS Stock Rises Overnight Despite Citi’s 64% Stake Cut — Retail Bulls Say SLS009 Alone Could Outvalue Sellas
stocktwits.com ·
- Sellas Life Sciences: SLS009 Delivers Real Signals, but the Subgroup Math Demands a Closer Read
ad-hoc-news.de ·
- SELLAS Life Sciences Group Inc (RXK3.DU) Seasonal returns chart
Yahoo Finance Singapore ·
SELLAS Life Sciences Group, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | $0 | $1.0M |
| Net income | -$26.9M | -$30.9M | -$37.3M | -$41.3M |
| Diluted EPS | $-0.25 | $-0.50 | $-1.34 | $-2.13 |
| Total assets (year end) | $78.3M | $19.4M | $6.2M | $20.9M |
| Cash and equivalents (year end) | $71.8M | $13.9M | $2.5M | $17.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About SELLAS Life Sciences Group, Inc.
- Ticker
- SLS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1390478
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Frequently asked questions
What exchange is SELLAS Life Sciences Group, Inc. listed on?
SELLAS Life Sciences Group, Inc. trades on the Nasdaq under the ticker symbol SLS.
What industry is SELLAS Life Sciences Group, Inc. in?
SELLAS Life Sciences Group, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is SELLAS Life Sciences Group, Inc. headquartered?
SELLAS Life Sciences Group, Inc.'s business address on file with the SEC is in New York, NY.
When does SELLAS Life Sciences Group, Inc.'s fiscal year end?
SELLAS Life Sciences Group, Inc.'s fiscal year ends on December 31.
How much revenue did SELLAS Life Sciences Group, Inc. report?
SELLAS Life Sciences Group, Inc. reported $0 in revenue for calendar year 2023, according to its SEC filings.